80 FR 8661 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 32 (February 18, 2015)

[Federal Register Volume 80, Number 32 (Wednesday, February 18, 2015)]
[Notices]
[Page 8661]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03255]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Comparison and Validation of 
Screening Tools for Substance Use Among Pregnant Women, DP15-003, 
initial review.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Time and Date

9:00 a.m.-6:30 p.m., March 18, 2015 (Closed)

    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Pub. L. 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Comparison and Validation of Screening Tools for Substance Use 
among Pregnant Women, DP15-003, initial review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, 
Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-03255 Filed 2-17-15; 8:45 am]
BILLING CODE 4163-18-P